| Eric Krantz, APRN | |
|
2020 Wellness Way Ste 504, Las Vegas, NV 89106-4145 | |
| (561) 271-3491 | |
| (702) 259-9595 |
| Full Name | Eric Krantz |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 2020 Wellness Way Ste 504, Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346702784 | NPI | - | NPPES |
| 818687 | Other | NV | NEVADA APRN LICENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 818687 (Nevada) | Secondary |
| 363L00000X | Nurse Practitioner | 818687 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sentara Williamsburg Regional Medical Center | Williamsburg, VA | Hospital |
| Sentara Careplex Hospital | Hampton, VA | Hospital |
| Riverside Regional Medical Center | Newport news, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healogics Specialty Physicians Of Virginia Llc | 1052637733 | 9 |
News Archive
A Washington State University research team has found that nanoscale particles of the most commonly used plastics tend to move through the water supply, especially in fresh water, or settle out in wastewater treatment plants, where they end up as sludge, in landfills, and often as fertilizer.
CRISPR-Cas9 is the go-to technique for knocking out genes in human cell lines to discover what the genes do, but the efficiency with which it disables genes can vary immensely.
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.
Executives from Senexis Limited (Cambridge,UK) signed an agreement with O2h (Ahmedabad, India) under which O2h will provide Senexis with chemistry services to support a patent filing on a novel chemical series that have shown potential in pre-clinical models, as disease modifying treatments for Alzheimer's Disease.
› Verified 3 days ago
| Entity Name | Healogics Specialty Physicians Of Virginia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689079055 PECOS PAC ID: 1052637733 Enrollment ID: O20150225000563 |
News Archive
A Washington State University research team has found that nanoscale particles of the most commonly used plastics tend to move through the water supply, especially in fresh water, or settle out in wastewater treatment plants, where they end up as sludge, in landfills, and often as fertilizer.
CRISPR-Cas9 is the go-to technique for knocking out genes in human cell lines to discover what the genes do, but the efficiency with which it disables genes can vary immensely.
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.
Executives from Senexis Limited (Cambridge,UK) signed an agreement with O2h (Ahmedabad, India) under which O2h will provide Senexis with chemistry services to support a patent filing on a novel chemical series that have shown potential in pre-clinical models, as disease modifying treatments for Alzheimer's Disease.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eric Krantz, APRN 2020 Wellness Way Ste 504, Las Vegas, NV 89106-4145 Ph: (561) 271-3491 | Eric Krantz, APRN 2020 Wellness Way Ste 504, Las Vegas, NV 89106-4145 Ph: (561) 271-3491 |
News Archive
A Washington State University research team has found that nanoscale particles of the most commonly used plastics tend to move through the water supply, especially in fresh water, or settle out in wastewater treatment plants, where they end up as sludge, in landfills, and often as fertilizer.
CRISPR-Cas9 is the go-to technique for knocking out genes in human cell lines to discover what the genes do, but the efficiency with which it disables genes can vary immensely.
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.
Executives from Senexis Limited (Cambridge,UK) signed an agreement with O2h (Ahmedabad, India) under which O2h will provide Senexis with chemistry services to support a patent filing on a novel chemical series that have shown potential in pre-clinical models, as disease modifying treatments for Alzheimer's Disease.
› Verified 3 days ago